Abstract
ObjectivesTo describe the distribution of costs based on potentially inappropriate prescribing (PIP) and adverse drug reaction (ADR) status in terms of total direct costs and costs caused by ADRs, among...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have